MCF7-MSC co-culture assay: Approach to assess the co-operation between MCF-7s and MSCs in tumor-induced angiogenesis

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 3 SUPPL., 2012, Pages 1071-1076

  Comsa S ^a   Ciuculescu, Felicia ^a   Henschler, R ^b   Raica, M ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Breast cancer; MCF 7; MSC; Transmigration

Indexed keywords

EID: 84865707754     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 2006, 8(4):315-317.
2. Lazennec G, Jorgensen C, Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells, 2008, 26(6):1387-1394.
3. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE, Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors, Stem Cells, 2006, 24(4):1030-1041.
4. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, 2004, 94(5):678-685.
5. Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M, Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke, J Cereb Blood Flow Metab, 2007, 27(10):1684-1691.
6. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J, Béliveau R, Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation, Stem Cells, 2003, 21(3):337-347.
7. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, Pernod G, Buehler L, Bounameaux H, Kruithof EK, Characterization of endothelial-like cells derived from human mesenchymal stem cells, J Thromb Haemost, 2007, 5(4):826-834.
8. Ball SG, Shuttleworth CA, Kielty CM, Vascular endothelial growth factor can signal through platelet-derived growth factor receptors, J Cell Biol, 2007, 177(3):489-500.
9. Roorda BD, ter Elst A, Kamps WA, de Bont ES, Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells, Crit Rev Oncol Hematol, 2009, 69(3):187-198.
10. Maestroni GJ, Hertens E, Galli P, Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice, Cell Mol Life Sci, 1999, 55(4):663-667.
11. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 2007, 449(7162):557-563.
12. Ball SG, Shuttleworth CA, Kielty CM, Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors, J Cell Mol Med, 2007, 11(5):1012-1030.
13. Burdall SE, Hanby AM, Lansdown MR, Speirs V, Breast cancer cell lines: friend or foe? Breast Cancer Res, 2003, 5(2):89-95.
14. Fierro FA, Sierralta WD, Epuñan MJ, Minguell JJ, Marrowderived mesenchymal stem cells: role in epithelial tumor cell determination, Clin Exp Metastasis, 2004, 21(4):313-319.
15. Rüster B, Grace B, Seitz O, Seifried E, Henschler R, Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay, Stem Cells Dev, 2005, 14(2):231-235.
16. Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, Henschler R, Rho inhibition induces migration of mesenchymal stromal cells, Stem Cells, 2007, 25(8):1966-1974.
17. Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E, Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells, Ann Surg, 2008, 247(2):310-314.
18. Manske M, Bade EG, Growth factor-induced cell migration: biology and methods of analysis, Int Rev Cytol, 1994, 155:49-96.
19. Tomanek RJ, Schatteman GC, Angiogenesis: new insights and therapeutic potential, Anat Rec, 2000, 261(3):126-135.
20. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM, Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells, Blood, 2001, 98(9):2615-2625.
21. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM, Origin of endothelial progenitors in human postnatal bone marrow, J Clin Invest, 2002, 109(3):337-346.
22. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C, Mesenchymal stem cells can be differentiated into endothelial cells in vitro, Stem Cells, 2004, 22(3):377-384.
23. Wu X, Huang L, Zhou Q, Song Y, Li A, Jin J, Cui B, Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth, Int J Cardiol, 2005, 105(3):274-282.
24. Hombauer H, Minguell JJ, Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells, Br J Cancer, 2000, 82(7):1290-1296.